Back to search results

Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast Cancer

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Anatomic Stage I Breast Cancer AJCC v8 · Anatomic Stage IA Breast Cancer AJCC v8 · Anatomic Stage IB Breast Cancer AJCC v8 · Anatomic Stage II Breast Cancer AJCC v8 · Anatomic Stage IIA Breast Cancer AJCC v8 · Anatomic Stage IIB Breast Cancer AJCC v8 · Anatomic Stage III Breast Cancer AJCC v8 · Anatomic Stage IIIA Breast Cancer AJCC v8 · Anatomic Stage IIIB Breast Cancer AJCC v8 · Anatomic Stage IIIC Breast Cancer AJCC v8 · Anatomic Stage IV Breast Cancer AJCC v8 · Endocrine Therapy-Induced Alopecia · Prognostic Stage I Breast Cancer AJCC v8 · Prognostic Stage IA Breast Cancer AJCC v8 · Prognostic Stage IB Breast Cancer AJCC v8 · Prognostic Stage II Breast Cancer AJCC v8 · Prognostic Stage IIA Breast Cancer AJCC v8 · Prognostic Stage IIB Breast Cancer AJCC v8 · Prognostic Stage III Breast Cancer AJCC v8 · Prognostic Stage IIIA Breast Cancer AJCC v8 · Prognostic Stage IIIB Breast Cancer AJCC v8 · Prognostic Stage IIIC Breast Cancer AJCC v8 · Prognostic Stage IV Breast Cancer AJCC v8

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States

    Contact: Study coordinator (Brittany L. Dulmage, MD) · brittany.dulmage@osumc.edu · 614-565-2554
    Contact: Principal Investigator (Brittany L. Dulmage, MD)
Study leads

  • Brittany L Dulmage, MD

    Principal Investigator

    Ohio State University Comprehensive Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)